Abstract
Mitochondrial membrane permeabilization can be a rate limiting step of apoptotic as well as necrotic cell death. Permeabilization of the outer mitochondrial membrane (OM) and/or inner membrane (IM) is, at least in part, mediated by the permeability transition pore complex (PTPC). The PTPC is formed in the IM/OM contact site and contains the two most abundant IM and OM proteins, adenine nucleotide translocator (ANT, in the IM) and voltage-dependent anion channel (VDAC, in the OM), the matrix protein cyclophilin D, which can interact with ANT, as well as apoptosis-regulatory proteins from the Bax/Bcl-2 family. Here we discuss that ANT has two opposite functions. On the one hand, ANT is a vital, specific antiporter which accounts for the exchange of ATP and ADP on IM. On the other hand, ANT can form a non-specific pore, as this has been shown by electrophysiological characterization of purified ANT reconstituted into synthetic lipid bilayers or by measuring the permeabilization of proteoliposomes containing ANT. Pore formation by ANT is induced by a variety of different agents (e.g. Ca2+, atractyloside, thiol oxidation, the pro-apoptotic HIV-1 protein Vpr, etc.) and is enhanced by Bax and inhibited by Bcl-2, as well as by ADP. In isolated mitochondria, pore formation by ANT leads to an increase in IM permeability to solutes up to 1500 Da, swelling of the mitochondrial matrix, and OM permeabilization, presumably due to physical rupture of OM. Although alternative mechanisms of mitochondrial membrane permeabilization may exist, ANT emerges as a major player in the regulation of cell death. Cell Death and Differentiation (2000) 7, 1146–1154
Similar content being viewed by others
Introduction
Mitochondrial membrane permeabilization (MMP) appears to be a near-to-general phenomenon associated with apoptosis.1,2,3 Schematically, three phases of the apoptotic process can be distinguished. During a pre-mitochondrial phase pro-apoptotic second messengers are activated and factors acting on mitochondrial membranes accumulate and/or translocate to mitochondria. Prominent pro-apoptotic proteins directly acting on mitochondria include the pro-apoptotic members of the Bcl-2/Bax family, as well as kinases and phosphatases which induce covalent modification of Bcl-2/Bax family members, thereby influencing their function and/or subcellular localization. p53 has also recently been shown to translocate to mitochondria.4 Non-protein factors acting on mitochondria include Ca2+, reactive oxygen species, NO, and ganglioside GD3 (reviewed in3,5,6,7). During the mitochondrial phase, MMP occurs, presumably through a limited set of mechanisms which are discussed in this special issue of Cell Death and Differentiation. Finally, during the post-mitochondrial phase, the functional consequences of MMP namely bioenergetic failure and/or release of potentially harmful proteins normally sequestered in mitochondria causes cell death.
The signs of MMP include the release of soluble proteins from the mitochondrial intermembrane space (e.g. cytochrome c, apoptosis inducing factor) through the outer membrane (OM), as well as a partial permeabilization of the inner membrane (IM) for solutes up to ∼1500 Da, leading to a reduction of the mitochondrial transmembrane potential (ΔΨm). IM permeabilization appears to be a less constant feature of apoptosis than OM permeabilization. Although cytochrome c release through OM is mostly associated with a permanent loss of ΔΨm,8 this ΔΨm reduction may be transient, indicating IM ‘resealing’.9,10,11 Moreover, in some cases cytochrome c release may occur in cells whose mitochondria have an apparently normal1,12 or even an increased ΔΨm.13
The mechanism of OM permeabilization is controversial. OM permeabilization has been proposed to occur independently from that of IM, e.g. due to the OM insertion and oligomerization of Bax-like molecules, which may or may not cooperate with the OM protein VDAC (voltage-dependent anion channel) to form large protein-permeable conduits.14,15 Alternatively, primary IM permeabilization to small ions and water may cause osmotic matrix swelling and consequent OM rupture, resulting because the surface area of the IM with its folded christae exceeds that of the OM. Accordingly, matrix swelling and herniation of IM through OM, with consequent physical rupture of OM, has been observed at the ultrastructural level in a variety of models of apoptosis (Table 1), including in hepatocytes exposed to CD95 crosslinking in vivo.16 Of note, matrix swelling is a feature of apoptosis which can only be observed transiently, before the cytoplasm (including mitochondria) undergoes apoptotic shrinkage.17
The present review will focus on one particular molecule involved in MMP, namely the IM protein ANT (adenine nucleotide translocator). We will advance several arguments why we believe ANT to be a key player in the regulation of cell-death associated MMP.
Normal structure and function of ANT
ANT, a ∼30 kDa protein exclusively localized to the IM, is involved in the specific exchange of ADP and ATP.18 ANT is an antiporter whose function is strictly required for ATP produced on the matrix side of IM by the F0/1 ATP synthase to be exported to the rest to the cell. Genetic inactivation of ANT therefore results into a severe metabolic impairment.19 Transport is driven by the ΔΨm leading to the net import of one positive charge per reaction cycle (exchange of ATP4− by ADP3−). In particular circumstances, when the respiratory chain (which normally generates the ΔΨm) is blocked, ANT may function in the opposite direction and import ATP into the matrix while exporting ADP (a reaction which then contributes to the generation of the ΔΨm), ATP consumption being mediated by the F0/1 ATP synthase functioning in its ATPase mode (which pumps protons out of the matrix while consuming ATP, thus generating a ΔΨm). As a result, the activity of ANT and F0/1 ATP synthase may be expected to be tightly coupled among each other.
In humans and rodents, three and two ANT isoforms exist, respectively, and are expressed in a strictly tissue-specific fashion.20 The human ANT2 isoform is selectively expressed in proliferating cells.21 In non-proliferating cells ANT2 expression appears to be negatively regulated by the general transcription factor Sp1,22 as well as specific hexanucleotide silencer element in the ANT2 promoter.23 All ANT isoforms are members of the family formed by the carriers of the mitochondrial IM. Proteins from this family are characterized by a tripartite structure with three repeated segments of about 100 amino acid residues each.24,25,26 Each of the repeated segments contains two peaks of hydrophobicity corresponding to two transmembrane helices (six in total), separated by a stretch of amino acids that protrude to the matrix (three in total). The N-terminus and the C-terminus of the ANT molecule are located on the intermembrane face of IM, and the linker regions between each of the repeated segments (two in total) form loops protruding into the intermembrane space.18 ANT is a basic protein whose excess cationic changes are at least partially compensated by close interaction with the acidic lipid cardiolipin,27 a lipid which is exclusively found within the IM. The native ANT is probably a dimer or an oligomer with an even number of molecules, based on the observation that a covalent tandem dimer of yeast ANT (generated by fusion of the C-terminus of the first repeat to the N-terminus of the second repeat) is functional.28
Two pharmacological ANT inhibitors interact with distinct binding sites of ANT. Bongkrekic acid (BA) binds to the matrix face of ANT, whereas carboxyatracyloside (or atractyloside, Atr) binds to the intermembrane side of the molecule. Interaction with BA forces ANT to adopt its m-state conformation, whereas Atr induces the c-state conformation. During the ADP/ATP exchange, the ANT molecule is thought to undergo major conformational changes, which probably are reflected by the m- and c-states respectively.29 These conformational changes are likely to involve the rearrangement of charged sites within the membrane.30,31 On the matrix side of ANT, ADP is likely to interact with the second matrix loop, since Lys162 of the bovine heart ANT interacts with radiolabelled 2-azido-ADP.18 Moreover, 7-azido-5-isopropyl-acridone, which reacts with Cys159, displaces ADP from its binding site.32 Oxidative stress induced by tert-butylhydroperoxide or diamide (which crosslinks Cys56 in the first matrix loop) reduces the affinity of ANT for ADP.33 Monovalent derivatization of Cys56 by the thiol-reactive agent methyl methanethiosulfonate causes an irreversible extrusion of the first loop facing the matrix and freezes the ANT in its m-state conformation.34 Intermolecular crosslinking of Cys56 residues by bifunctional dimaleimides only causes dimerization of ANT in its m-state, but not in its c-state,35 and inhibits the antiporter activity of ANT. Dimerization can be achieved with dimaleimide in which the distance between the two maleimide groups ranges from 8 to 17 Å, with an optimum at 12 Å, suggesting a (regulatory?) fluctuation of the loop containing Cys56.35
ANT as a pore-forming protein
The biochemical features of ANT can be best studied by reconstituting the purified protein into synthetic lipid bilayers, either in proteoliposomes or in planar membranes. Hydrophilic compounds with a relative mass <1500 Da (e.g. malate, 3H-glucose, calcein, 4-methylumbelliferone phosphate) can be encapsulated in proteoliposomes and their release can be quantitated via a variety of different techniques (enzymatically in the case of malate, radioactivity in the case of 3H-glucose, fluorescence dequenching in the case of calcein, alkaline phosphatase-mediated conversion to a fluorescent product, 4-methylumbelliferone, in the case of 4-methylumbelliferone phosphate).36,37,38 Using this experimental set-up, it has been shown that ANT proteoliposomes but not control liposomes lacking ANT become permeabilized in response to atractyloside,37 Ca2+,36 the thiol crosslinker diamide,38 the ROS donor tert-butylhydroperoxide, Bax,37 and viral protein R (Vpr) encoded by human immunodeficiency virus-1 (HIV-1).39 These data indicate that ANT can mediate permeabilization in response to several agents which reportedly induce mitochondrial membrane permeabilization and apoptosis. Of note, non-specific pore formation has also been reported for other members of the mitochondrial carrier family. Thus, following treatment with thiol-specific chemical reagents, the aspartate/glutamate carrier can be converted from an obligatory exchange antiporter to a channel-like uniporter.40 After deletion of a stretch of nine amino acid in the third matrix loop, uncoupling protein (UCP) becomes a non-specific pore.41 Whether native UCP also may form a pore in a more physiological context, however, remains elusive.
Electrophysiological experiments confirm that ANT can form channels (Table 2). Single channel current measurements of excised patches with reconstituted purified ANT indicate that Ca2+ can induce the formation of large channels with multiple subconductance states varying from 70 to 600 pS, depending on the ion concentration.42,43 Channel formation is inhibited by low pH (<5.2), ADP and bongkrekate.42 Single channel recordings revealed that ANT can also form relatively small channels (30 pS) in response to its ligand Atr.43 A mixture of Bax and ANT (molar ratio 1 : 4) has a higher probability of Atr-induced pore openings and exhibits two different conductance levels (30 and 80 pS), as well as cation specificity (whereas Bax alone forms an anion-selective channel). When employed at relatively low doses (1 nM), Bax does not yield any major macroscopic conductance, unless combined with ANT treated with Atr. Thus, the combination of ANT+Atr+Bax forms a much more efficient membrane permeabilizing channel than do the combinations ANT+Atr, ANT+Bax, or Atr+Bax. The ANT/Bax cooperation is not observed when wild type Bax is replaced by two mutant proteins which have lost their apoptogenic potential:44,45 Bax ΔIGDE, which lacks a homodimerization domain in the BH3 region, and Bax Δα5/6, which lacks a putative pore forming domain. Preincubation of ANT with its physiological ligand ATP completely inhibits the channel activity mediated by ANT+Atr+Bax.43 The combination of ANT plus Bcl-2 (molar ratio 1 : 1) results in a virtual cessation of Atr-induced ion movement indicative of the closure of both ANA and Bcl-2 channels.43 If Bcl-2 is replaced by a mutant protein (Bcl-2 Δα5/6) lacking a putative pore formation domain,45,46 the inhibition of ANT-mediated conductance is suboptimal (Table 2). In conclusion, Bax and ANT can cooperate by forming a new class of channels which acquire distinct electrophysiological properties as well as a far higher probability of opening than either of the two compounds on its own. Moreover, Bcl-2 and ANT exhibit mutual inhibition of ion channel formation in vitro.
ANT-interacting, apoptosis-regulatory proteins
ANT can interact with a large number of proteins involved in the regulation of MMP and apoptosis (Figure 1). Thus, ANT is part of a multiprotein ensemble, the permeability transition pore complex (PTPC), which forms in the contact site between IM and OM.47 In this section, we will briefly enumerate proteins that have been shown to physically interact with ANT.
Cyclophilin D
Cyclophilin D is the mitochondrial target of cyclosporin A (CsA) and the non-immunosuppressive CsA derivative and N-methyl-4-Val-CsA, both of which inhibit the PTPC and can inhibit apoptosis in various in vitro and in vivo models.16,48 When immobilized on a column, purified recombinant cyclophilin D specifically retains ANT among triton-solubilized IM preparations49 and ANT plus VDAC among whole mitochondrial membrane extracts.50 Binding of cyclophilin D to purified mitochondrial IM is inhibited by CsA and enhanced by treatment with tert-butylhydroperoxide and by diamide,51 suggesting that the cyclophilin-D-ANT interaction favors mitochondrial membrane permeabilization.
Proteins from the Bcl-2/Bax family
ANT has been shown to interact directly with Bcl-2, Bcl-XL, Bax and Bak by three independent techniques: co-purification, co-immunoprecipitation and yeast-two-hybrid screening.37,47 This latter technique revealed that a short stretch of human ANT2 (amino acids 105–156) suffices for the interaction with Bcl-2-related proteins.37 As discussed above, it appears that Bax can cooperate with ANT to form pores, whereas Bcl-2 prevents the ANT-dependent pore formation in synthetic membranes. Bax-induced MMP can be inhibited by the ANT ligand bongkrekic acid,37,52 underlining the probable relevance of the ANT-Bax interaction.
VDAC
VDAC binds to ANT.53 VDAC is generally considered as the principal OM protein allowing for the OM transit of metabolites <5000 kDa. VDAC has been suggested to be the mitochondrial target of the pro-apoptotic proteins Bax and Bcl-2, which would allow VDAC to form a cytochrome c-permeant conduit.14 Intriguingly, the VDAC1 gene is transcriptionally upregulated in a model of γ-irradiation-induced apoptosis.54
Peripheral benzodiazepin receptor
The peripheral benzodiazepin receptor (PBR, also called mitochondrial diazepam binding receptor) co-purifies with ANT and VDAC.55 PBR, an OM protein, is a pharmacological target for cytotoxic drugs. Thus PBR ligands such as PK111195 (1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-isoquinolinecarboxamide), FGIN-I-27 (N,B-di-n-hexyl 2-(4-fluorophenyl)indole-3-acetamide), and chlorodiazepam enhance the apoptogenic effects of a variety of agents including TNF,56 ceramide, doxorubicin, etoposide,57 arsenite,58 or lonidamine59 and overcome the cytoprotective effects of Bcl-2.57,58,59
Creatine kinase
Creatine kinase co-purifies with ANT and VDAC. It appears that the creatine kinase octamer can inhibit pore formation by ANT.60 Creatine and creatine phosphate may have cytoprotective effects in some models of cell death.61,62
The protein kinase src
An N-terminally myristylated peptide derived from src binds to ANT in vitro.63 However, at present it is not clear whether intact protein kinases from the src family bind to mitochondria in intact cells.
Viral effectors
The anti-apoptotic protein vMIA, a product of the cytomegalovirus UL37 gene, has been shown to specifically interact with ANT.64 Similarly, viral protein R (Vpr), a pro-apoptotic protein encoded by human immunodeficiency virus-1 (HIV-1) specifically binds to ANT with an affinity in the nanomolar range.39
Pharmacological and genetic evidence that ANT participates in cell death regulation in intact cells
Bongkrekic acid, a specific ANT ligand which prevents pore formation by ANT, can inhibit the induction of apoptosis in a number of different experimental systems (Table 3). Pharmacological evidence suggests that ANT itself is the target of several apoptosis-inducing agents. Thus, MMP and apoptosis induction by means of the thiol-crosslinking agent diamide correlates with oxidation of Cys56 of ANT, as well as with ANT dimerization.38,65 Fatty acid anions (e.g. palmitate or stearate), including a non-metabolizable analogue β,β′-methyl substituted hexadecane α,ω-dioic acid, uncouple mitochondria via an effect on ANT,66 who facilitates their electrophoretic translation from the inner to the outer leaflet of IM.67 Palmitate also induces apoptosis when added to intact cells and this effect is inhibited by BA, indicating the involvement of ANT.68 Some non-steroidal anti-inflammatory drugs (e.g. diclofenac) both induce PTPC opening and inhibit ANT activity in purified mitochondria.69 The unsaturated aldehydes 4-hydroxynonenal and 4-hydroxyhexenal, which arise as a by-product of lipid peroxidation and have potent cytotoxic and MMP-inducing activities, also inhibit the antiport activity of ANT reconstituted into liposomes.70
More convincingly, genetic experiments confirm the participation of ANT in the control of cell death. Yeast cells in which the three ANT isoenzymes have been inactivated by homologous recombination are relatively resistant against killing by Bax37 and Vpr.39 Inactivation of the ANT isoenzyme 2 alone suffices to render yeast cells relatively resistant to Bax.71 Inactivation of F1/0 ATPase subunits also yields Bax-resistant cells.71,72 On theoretical grounds, it may be speculated that the suppression of mitochondrial ATP synthesis/consumption should paralyse the antiporter function of ANT (and perhaps reduce the probability that ANT adopts the pore-forming conformation). Transfection-enforced overexpression of mouse ANT1 (but not ANT2) induces apoptosis in mammalian cells. This is not due to a non-specific toxic effect of the overexpressed protein, because ANT1-induced apoptosis is abolished by co-transfection with cDNA coding for cyclophilin D.73 The N-terminal half of ANT-1 (aa 1–141) conserves its cytocidal potential. However, further truncation of ANT-1, from aa 102 to the C-terminus, abolishes its apoptogenic effect. Hence, a critical region of ANT1 (aa 102–141) is required for apoptosis induction. Intriguingly, this region overlaps with the Bcl-2/Bax binding site of ANT (aa 105–156)37 and contains a Vpr-binding peptide motif (WXXF; aa 110–114;74) within the C-terminal half of the first intermembrane loop (aa 103–115) (Figure 2). It is tempting to speculate that the apoptosis-regulatory domain of the ANT protein (aa 103–142), which comprises the third transmembrane domain (aa 116–134), may participate in ANT-mediated pore formation. Intriguingly, the Bcl-2/Bax binding site also overlaps with the region of ANT (aa 148–156) in which the three ANT isoforms exhibit the strongest level of divergence, suggesting an iso-form specific regulation of ANT at this level.
Open questions and perspectives
At least in some models of apoptosis, a transient ΔΨm increase precedes the later ΔΨm collapse.75 According to a recent study,76 overexpression of Bax induces alkalinization of the mitochondrial matrix accompanied by cytosolic acidification,76 as well as an increase in the ΔΨm before the ΔΨm drops.76 This effect is observed both in mammalian and in yeast cells and can be recapitulated in mammalian cells exposed to the universal apoptosis inducer staurosporin.76 Given the fact that Bax can inhibit the ATP/ADP antiporter function of ANT (A-S Belzacq and C Brenner, unpublished observations), and that the ATP/ADP exchange reaction is compromised in mitochondria from pre-apoptotic cells,77 the following scenario becomes plausible (Figure 3): Early during apoptosis, Bax (and perhaps other pro-apoptotic members of the Bcl-2 family) would translocate to mitochondria and interact with ANT to inhibit its antiporter activity, before facilitating ANT-mediated pore formation. Indeed, pore formation by Bax+ANT in artificial membranes requires the action of additional factors (e.g. atractyloside, Vpr) which impinge on the conformation of ANT.37,39,43 As a net result of Bax-mediated antiporter inhibition, ATP would accumulate in the matrix, while matrix ADP would decline until the F1/0 ATPase would be forced to operate in its ATPase mode, thereby increasing the ΔΨm and generating phosphate (which via activation of the hydroxide/phosphate carrier would cause matrix alkalinization). Accordingly, F1/0 ATPase inhibition by oligomycin prevents the bax-induced ΔΨm increase, matrix alkalinization, cytosolic acidification, and apoptosis.76 During later stages of the process, matrix alkalinization, local imbalances in the ATP/ADP concentration, increases in the production of ROS etc. would favor pore formation by ANT, aided by Bax, thereby favoring the ΔΨm loss and complete loss of mitochondrial function. This scenario provides an exciting working hypothesis (Figure 3) which fits well the existing experimental data, yet requires further exploration in cell-free systems.
Although ANT is probably a major pore-forming/pore-regulating protein involved in the control of apoptosis, it appears clear that other proteins contained within the PTPC (VDAC, Bax, Bcl-2 etc.) may also function as pore-forming units, perhaps independently of ANT. Resolving the question to which extent individual PTPC proteins can function in the control of MMP and apoptosis will require thorough investigation of their function by multiple methods, including their reconstitution into lipid bilayers and genetic modifications in mammalian cells. Furthermore, numerous questions remain without response. How is it possible that proteins that are generally thought to be confined to OM (Bcl-2, Bax) can interact with the IM protein ANT? Do they translocate to IM? Or do protruding domains of IM-anchored Bcl-2/Bax protein (or OM-anchored ANT) bind to OM (or IM, respectively), within the OM/IM contact sites? Do all ANT (and VDAC) molecules participate in the control of apoptosis, or is this function restricted to the small fraction of molecules localized in the contact site? What are the exact conformational changes explaining cooperative channel formation by sessile mitochondrial proteins and Bax? What submolecular events do determine the switch from the antiporter mode to the pore-forming mode? In which specific signal transduction pathways does ANT participate at MMP, and when is it dispensable for MMP to occur? Are there differences in the pore-forming function between distinct ANT isoforms? Can other members of the mitochondrial carrier protein family participate in MMP regulation? Answering to these questions may provide tantalizing insights into cell death control mechanisms and open therapeutic avenues to the specific pharmacological manipulation of apoptosis.
Abbreviations
- ANT:
-
adenine nucleotide translocator
- IM:
-
inner membrane
- OM:
-
outer membrane
- PTPC:
-
permeability transition pore complex
- SIMPs:
-
soluble intermembrane space proteins
- VDAC:
-
voltage dependent anion channel
References
Green DR and Reed JC . 1998 Mitochondria and apoptosis. Science 281: 1309–1312
Green DR and Kroemer G . 1998 The central executioner of apoptosis: mitochondria or caspases? Trends Cell Biol. 8: 267–271
Kroemer G and Reed JC . 2000 Mitochondrial control of cell death. Nature Med. 6: 513–519
Marchenko ND, Zaika A and Moll UM. . 2000 Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275: 16202–16212
Kroemer G . 1997 The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3: 614–620
Gross A, McDonnell JM and Korsmeyer SJ . 1999 Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13: 1899–1911
Vander Heiden MG and Thompson CB . 1999 Bcl-2 proteins: Inhibitors of apoptosis or regulators of mitochondrial homeostasis? Nat. Cell Biol. 1: E209–E216
Heiskanen KM, Bhat MB, Wang HW, Ma JJ and Nieminen AL . 1999 Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J. Biol. Chem. 274: 5654–5658
Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P and Di Lisa F . 1999 Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76: 725–734
Pastorino JG, Tafani M, Rothman RJ, Macineviciute A, Hoek JB and Farber JL . 1999 Functional consequences of sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274: 31734–31739
Szalai G, Krischnamurthy R and Hajnoczky G . 1999 Apoptosis driven by IP3-linked mitochondrial calcium signals. EMBO J. 18: 6349–6361
Goldstein JC, Waterhouse NJ, Juin P, Evan GI and Green DR . 2000 The coordinate release of cytochrome c is rapid, complete and kinetically invariant. Nat. Cell Biol. 2: 156–162
Van der Heiden M, Chandel NS, Schumacker PT and Thompson CB . 1999 Bcl-XL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell. 3: 159–167
Shimizu S, Narita M and Tsujimoto Y . 1999 Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483–487
Eskes R, Desagher S, Antonsson B and Martinou JC . 2000 Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20: 929–935
Feldmann G, Haouzi D, Moreai A, Durand-Schneider AM, Bringuier A, Berson A, Mansouri A, Fau D and Pessayre D . 2000 Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 31: 674–683
Dallaporta B, Marchetti P, de Pablo M, Maisse C, Duc HT, Metivier D, Zamzami N, Geuskens M and Kroemer G . 1999 Plasma membrane potential in thymocyte apoptosis. J. Immunol. 162: 6534–6542
Fiore C, Tezeguet V, LeSaux A, Roux P, Schwimmer C, Dianoux AC, Noel F, Lauquin GJM, Brandolin G and Vignais PV . 1998 The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie 80: 137–150
Graham BH, Waymire KG, Cottrell B, Trounce JA, MacGregor GR and Wallace DC . 1997 A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genet. 16: 226–234
Doerner A, Pauschinger M, Badorff A, Noutsias M, Giessen S, Schulze K, Bilger J, Rauch U and Schultheiss HP . 1997 Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett. 414: 258–262
Barath P, Luciakova K, Hodny Z, Li RG and Nelson BD . 1999 The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp. Cell. Res. 248: 583–588
Zaid A, Li RG, Luciakova K, Barath P, Nery S and Nelson BD. . 1999 On the role of the general transcription factor Sp1 in the activation and repression of diverse mammalian oxidative phosphorylation genes. J. Bioenerg. Biomembr. 31: 129–135
Barath P, Albert-Fournier B, Luciakova K and Nelson BD . 1999 Characterization of a silencer element and purification of silencer protein that negatively regulates the human adenine nucleotide translocator 2 promoter. J. Biol. Chem. 274: 3378–3384
Walker JE and Runswick MJ . 1993 The mitochondrial transport protein superfamily. J. Bioenerg. Biomembr. 25: 435–446
Kuan J and Saier MHJ . 1993 The mitochondrial carrier family of transport proteins: structural, functional, and evolutionary relationships. Crit. Rev. Biochem. Mol. Biol. 28: 209–233
Nelson DR, Lawson JE, Klingenberg M and Douglas MG . 1993 Site-directed mutagenesis of the yeast mitochondrial ADP ATP translocator - 6 arginines and one lysine are essential. J. Mol. Biol. 230: 1159–1170
Beyer K and Nuscher B . 1996 Specific cardiolipin binding interferes with laveling of sulfhydril residues in the adenosine diphosphate/adenosine triphosphate carrier protein from beef heart mitochondria. Biochemistry 35: 15784–15790
Hatanaka T, Hashimoto M, Majima E, Shinohara Y and Terada H . 1999 Functional expression of the tandem-repeated homodimer of the mitochondrial ADP/ATP carrier in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 262: 726–730
Gropp T, Bustovetsky N, Klingenberg M, Muller V, Fendler K and Bamberg E . 1999 Kinetics of electrogenic transport by the ADP/ATP carrier. Biophys. J. 77: 714–726
Brustovetsky N, Becker A, Klingenberg M and Bamberg E . 1996 Electrical currents associated with nucleotide transport by the reconstituted mitochondrial ADP/ATP carrier. Proc. Natl. Acad. Sci. USA. 93: 664–668
Nelson DR, Felix CM and Swanson JM . 1998 Highly conserved charge-pair networks in the mitochondrial carrier family. J. Mol. Biol. 277: 285–308
Oettmeier W, Masson K and Kalinna S . 1995 [3H]7-azido-4-isopropylacrione labels Cys159 of the bovine mitochondrial ADP/ATP-carrier protein. Eur. J. Biochem. 227: 730–733
Halestrap AP, Woodfield KY and Connern CP . 1997 Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272: 3346–3354
Hashimoto M, Majima E, Hatanka T, Shinohara Y, Onishi M, Goto S and Terada H . 2000 Irreversible extrusion of the first loop facing the matrix of the bovine heart mitochondrial ADP/ATP carrier by labeling the Cys56 residue with the SH-reagent methyl methanethiosulfonate. J. Biochem. 127: 443–449
Hashimoto M, Majima E, Goto S, Shinohara Y and Terada H . 1999 Fluctuation of the first loop facing the matrix of the mitochondrial ADP/ATP carrier deduced from intermolecular cross-linking of Cys56 residues by bifunctional dimaleimides. Biochemistry 38: 1050–1056
Rück A, Dolder M, Wallimann T and Brdiczka D . 1998 Reconstituted adenine nucleotide translocator forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Lett. 426: 97–101
Marzo I, Brenner C, Zamzami N, Jürgensmeier J, Susin SA, Vieira HLA, Prévost M-C, Xie Z, Mutsiyama S, Reed JC and Kroemer G . 1998 Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027–2031
Costantini P, Belzacq A-S, Vieira HLA, Larochette N, de Pablo M, Zamzami N, Susin SA, Brenner C and Kroemer G . 2000 Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 19: 307–314
Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HLA, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Brian JP, Irinopoulos T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP and Kroemer G . 2000 The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191: 33–45
Dierks T, Salenin A, Heberger C and Krämer R . 1990 The mitochondrial aspartate/glutamate and ADP/ATP carrier switch from obligate counter exchange to unidirectional transport after modification by SH-reagents. Biochim. Biophys. Acta. 1028: 268–280
González Barroso MM, Fleury C, Levi Meyrueis C, Zaragoza P, Bouillaud F and Rial E . 1997 Deletion of amino acids 261-269 in the brown fat uncoupling protein converts the carrier protein into a pore. Biochemistry 36: 10930–10935
Brustovetsky N and Klingenberg M . 1996 Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry 35: 8483–8488
Brenner C, Cardiou H, Vieira HLA, Zamzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC and Kroemer G . 2000 Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19: 329–336
Ying XM, Oltvai ZN and Korsmeyer SJ . 1994 BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321–323
Matsuyama S, Schendel SL, Xie Z and Reed JC . 1998 Cytoprotection by Bcl-2 requires the pore-forming alpha 5 and alpha 6 helices. J. Biol. Chem. 273: 30995–31001
Schendel S, Xie Z, Montal MO, Matsuyama S, Montal M and Reed JC . 1997 Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94: 5113–5118
Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Rémy R, Xie Z-H, Reed JC and Kroemer G . 1998 The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J. Exp. Med. 187: 1261–1271
Khaspekov L, Friberg H, Halestrap A, Viktorov I and Wieloch T . 1999 Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur. J. Neurosci. 11: 3194–3198
Woodfield K, Ruck A, Brdiczka D and Halestrap AP . 1998 Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 336: 287–290
Crompton M, Virji S and Ward JM . 1998 Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258: 729–735
Connern CP and Halestrap AP . 1996 Chaotropic agents and increased matrix volume enhance binding of mitochondrial cyclophilin to the inner mitochondrial membrane and sensitize the mitochondrial permeability transition to Ca2+. Biochemistry 35: 8172–8180
Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H and Tsujimoto Y . 1998 Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95: 14681–14686
Buhler S, Michels J, Wendt S, Ruck A, Brdiczka D, Welte W and Przybylski M . 1998 Mass spectrometric mapping of ion channel proteins (porins) and identification of their supramolecular membrane assembly. Protein Structure Function Gen. S2: 63–73
Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA, Steinman L and Herzenberg LA . 2000 Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. USA. 97: 2680–2685
McEnery MW, Snowman AM, Trifiletti RR and Snyder SH . 1992 Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA. 89: 3170–3174
Pastorino JG, Simbula G, Yamamoto K, Glascott PAJ, Rothman RJ and Farber JL . 1996 The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271: 29792–29799
Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M and Kroemer G . 1998 PK11195, a ligand of the mitochondrial benzodiazepin receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell. Res. 241: 426–434
Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed JC and Kroemer G . 1999 Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell. Res. 249: 413–421
Ravagnan L, Marzo I, Costantini P, Susin SA, Zamzami N, Petit PX, Hirsch F, Poupon M-F, Miccoli L, Xie Z, Reed JC and Kroemer G . 1999 Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 18: 2537–2546
Beutner G, Ruck A, Riede B and Brdiczka D . 1998 Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication of regulation of permeability transition by the kinases. Biochim. Biophys. 1368: 7–18
Kanazawa A, Tanaka A, Iwata S, Satoh S, Hatano E, Shinohara H, Kitai T, Tsunekawa S, Ikai I, Yamamoto M, Takahashi R, Chance B and Yamaoka Y . 1998 The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death. J. Surg. Res. 80: 229–235
Klivenyi P, Ferrante RJ, Matthews RT, Bogdnaow MB, Klein AL, Andrassen OA, Mueller G, Wermer M, Kaddurah-Daouk R and Beal F . 1999 Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med. 5: 347–350
Sigal CT and Resh MD . 1993 The ADP/ATP carries is the 32-kilodalton receptor for an NH2-terminally myristylated src peptide but not for pp60src polypeptide. Mol. Cell. Biol. 13: 3084–3092
Goldmacher VS, Bartle LM, Skletskaya S, Dionne CA, Kedersha NL, Vater CA, Han JW, Lutz RJ, Watanabe S, McFarland EDC, Kieff ED, Mocarski ES and Chittenden T . 1999 A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA. 96: 12536–12541
Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R and Kroemer G . 1998 The thiol-crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 16: 1055–1063
Hermesh O, Kalderon B and Bar Tana J . 1998 Mitochondrial uncoupling by a long chain fatty acyl analogue. J. Biol. Chem. 273: 3937–3942
Skulachev VP . 1999 Anion carriers in fatty acid-mediated physiological uncoupling. J. Bioenerg. Biomembr. 31: 431–435
de Pablo M, Susin SA, Jacotot E, Larochette N, Costantini P, Ravagnan L, Zamzami N, and Kroemer G . 1999 Palmitate induced apoptosis via a direct effect on mitochondria. Apoptosis 4: 81–87
Moreno Sanchez R, Bravo C, Vasquez C, Ayala G, Silveira LH and Martinez Lavin M . 1999 Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs. Study in mitochondria, submitochondrial particles, and whole cells. Biochem. Pharmacol. 57: 743–752
Chen JI, Bertrand H and Yu BP . 1995 Inhibition of adenine-nucleotide translocator by lipid peroxidation products. Free Radic Biol. Med. 19: 583–590
Harris MH, Vander Heiden MG, Kron SJ and Thompson CB . 2000 Role of oxidative phosphorylation in Bax toxicity. Mol. Cell. Biol. 20: 3590–3596
Matsuyama S, Xu Q, Velours J and Reed JC . 1998 Mitochondrial F0F1-ATPase proton pump is required for function of proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. 1: 327–336
Bauer MKA, Schubert A, Rocks O and Grimm S . 1999 Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell. Biol. 147: 1493–1501
Bou Hamdan M, Xue Y, Baudat Y, Hu B, Sire J, Pomerantz RJ and Duan LX . 1998 Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J. Biol. Chem. 273: 8009–8016
Vander Heiden MG, Chandal NS, Williamson EK, Schumacker PT and Thompson CB . 1997 Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627–637
Matsuyama S, Llopis J, Deveraux QL, Tsien RY and Reed JC . 2000 Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol. 2: 318–325
Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Columbini M and Thompson CB . 2000 Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc. Natl. Acad. Sci. USA. 97: 4666–4671
Angermuller S, Kunstle G and Tiegs G . 1998 Pre-apoptotic alterations in hepatocytes of TNF alpha-treated galactosamine-sensitized mice. J. Histochem. Cytochem. 46: 1175–1183
Teranishi M, Karbowski M, Kurono C, Soji K and Wakabayashi T . 1999 Two types of the enlargement of mitochondria related to apoptosis: simple swelling and the formation of megamitochondria. J. Electron Microsc. (Tokyo) 48: 637–651
Guastadisegni C, Balduzzi M, Mancuso MT and DiConsiglio E . 1999 Liver mitochondria alterations in chloroform-treated Sprague-Dawley rats. J. Toxicol. Environ. Health 57: 415–429
Kwong J, Choi HL, Huang Y and Chan FL . 1999 Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res. 298: 123–136
Buki A, Onkonkwo DO, Wang KKW and Pavlishock JT . 2000 Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20: 2825–2834
Sun YD, Clinkenbeard KD, Ownby CL, Cudd L, Clarke CR and Highlander SK . 2000 Ultrastructural characterization of apoptosis in bovine lymphocytes exposed to Pasteurella haemolytica leukotoxin. Am. J. Vet. Res. 61: 51–56
Madesh M, Ramachandran A, Pulimooed A, Vadranam M and Balasubramanian KA . 2000 Attenuation of intestinal ischemia/reperfusion injury with sodium nitroprusside: studies on mitochondrial function and lipid changes. Biochim. Biophys. Acta. 1500: 204–216
Hirose K, Westrum IE, Stone JS, Zirpel L and Rubel EW . 1999 Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann. NY Acad. Sci. 884: 389–409
Rippo MR, Malisan F, Ravagnan L, Condo I, Tomassini B, Costantini P, Todaro M, Susin SA, Rufini A, Kroemer G and Testi R . 2000 Ganglioside GD3 directly targets mitochondria and induces the release of apoptogenic factors. FASEB J. 14: 2047–2054
Robb SJ, Gospers LD, Wright KJ, Thomas AP and Connor JR . 1999 Influence of nitric oxide on cellular and mitochondrial integrity in oxidatively stressed astrocytes. J. Neurosci. Res. 56: 166–176
Ferrand Drake M, Friberg H and Wieloch T . 1999 Mitochondrial permeability transition induced DNA-fragmentation in the rat hippocampus following hypoglycemia. Neuroscience 90: 1325–1338
Okuno S, Shimizu S, Ito T, Nomura M, Hamada E, Tsujimoto Y and Matsuda H . 1998 Bcl-2 prevents caspase-independent cell death. J. Biol. Chem. 273: 34272–34277
Sugimoto T, Xiao C and Ichikawa H . 1998 Neonatal primary neuronal death induced by capsaicin and axotomy involves an apoptotic mechanism. Brain Res. 807: 147–154
Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi M, Bernard A, Mermod J-J, Mazzei G, Maundrell K, Gambale F, Sadoui R and Martinou J-C . 1997 Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370–376
Schlesinger PH, Gross A, Yin XM, Yamamoto K, Saito M, Waksman G and Korsmeyer SJ . 1997 Comparison of the ion channel characteristics of proapoptotic Bax and antiapoptotic Bcl-2. Proc. Natl. Acad. Sci. USA. 94: 11357–11362
Shimizu S, Konishi A, Kodama T and Tsujimoto Y . 2000 BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. USA 97: 3100–3105
Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Haeffner A, Hirsch F, Geuskens M and Kroemer G . 1996 Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184: 1155–1160
Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, Susin SA, Masse B and Kroemer G . 1996 Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157: 4830–4836
Doi T, Motoyama N, Tokunaga A and Watanabe T . 1999 Death signals from the B cell antigen receptor target mitochondria, activating necrotic and apoptotic death cascades in a murine B cell line, WEHI-231. Int. Immunol. 11: 933–941
Hehner SP, Hofmann TG, Ratter F, Dumont A, Dröge W and Schmitz ML . 1998 Tumor necrosis factor-alpha induced cell killing and activation of transcription factor NF-kappa B are uncoupled in L929 cells. J. Biol. Chem. 273: 18117–18121
Pastorino JG and Hoeck JB . 2000 Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31: 1141–1152
Watson RWG, O'Neill A, Brannigen AE, Coffey R, Marshall JC, Brady HR and Fitzpatrick JM. . 1999 Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent. FEBS Lett. 453: 67–71
Dumont A, Hehner SP, Hofmann TG, Ueffing M, Droge W and Schmitz ML . 1999 Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappa B. Oncogene 18: 747–757
Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME and Debatin KM . 1998 Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273: 33942–33948
Furlong IJ, Lopez Medivilla C, Ascaso R, Lopez Rivas A and Collins MKL . 1998 Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification. Cell Death Differ. 5: 214–221
Budd SL, Tenneti L, Lishnak T and Lipton SA . 2000 Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA. 97: 6161–6166
Stridh H, Fava E, Single B, Nicotera P, Orrenius S and Leist M . 1999 Tributyltin-induced apoptosis requires glycolytic adenosine triphosphate production. Chem. Res. Toxicol. 12: 874–882
Sakai H, Kobayashi Y, Sakai E, Shibata M and Kato Y . 2000 Cell adhesion is a prerequisite for osteoclast survival. Biochem. Biophys. Res. Commun. 270: 550–556
Mastrangelo AJ, Zou SF, Hardwick JM and Betenbaugh MJ . 1999 Antiapoptosis chemicals prolong productive lifetimes of mammalian cells upon Sindbis virus vector infection. Biotechnol. Bioeng 65: 298–305
Acknowledgements
This work has been supported by a special grant from the Ligue Nationale contre le Cancer, Comité Val de Marne de la Ligue contre le Cancer, as well as grants from ANRS, FRM, and the European Commission (to G Kroemer). HLA Vieira receives a fellowship from the Fundação para a Ciência e a Tecnolgia PRAXIS XXI, Portugal.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by G Kroemer
Rights and permissions
About this article
Cite this article
Vieira, H., Haouzi, D., El Hamel, C. et al. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ 7, 1146–1154 (2000). https://doi.org/10.1038/sj.cdd.4400778
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400778
Keywords
This article is cited by
-
Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma
Cell Death & Disease (2013)
-
Mitochondrial Delivery of Doxorubicin by Triphenylphosphonium-Functionalized Hyperbranched Nanocarriers Results in Rapid and Severe Cytotoxicity
Pharmaceutical Research (2013)
-
Understanding the mechanistic roles of 30Kc6 gene in apoptosis and specific productivity in antibody-producing Chinese hamster ovary cells
Applied Microbiology and Biotechnology (2012)
-
Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats
Journal of Translational Medicine (2011)
-
Carbon monoxide prevents hepatic mitochondrial membrane permeabilization
BMC Cell Biology (2011)